| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 12 | 2018 | 120 | 2.990 |
Why?
|
| CRISPR-Cas Systems | 10 | 2024 | 277 | 2.200 |
Why?
|
| Gene Editing | 8 | 2024 | 197 | 2.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 7 | 2017 | 85 | 1.350 |
Why?
|
| Teratoma | 3 | 2018 | 120 | 1.300 |
Why?
|
| Embryo, Mammalian | 5 | 2024 | 447 | 1.230 |
Why?
|
| Embryonic Germ Cells | 2 | 2018 | 4 | 1.050 |
Why?
|
| Mice | 49 | 2025 | 17693 | 1.010 |
Why?
|
| Mice, Knockout | 20 | 2025 | 3720 | 1.010 |
Why?
|
| Time-Lapse Imaging | 1 | 2024 | 6 | 0.870 |
Why?
|
| Embryonic Development | 2 | 2024 | 220 | 0.790 |
Why?
|
| Cell Differentiation | 6 | 2025 | 1871 | 0.780 |
Why?
|
| Animals | 51 | 2025 | 33208 | 0.700 |
Why?
|
| Machine Learning | 1 | 2024 | 325 | 0.670 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 4513 | 0.640 |
Why?
|
| Embryonal Carcinoma Stem Cells | 2 | 2018 | 4 | 0.640 |
Why?
|
| Germ Cells | 4 | 2023 | 196 | 0.590 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 3269 | 0.590 |
Why?
|
| Cyclin D1 | 2 | 2016 | 108 | 0.570 |
Why?
|
| Osteoblasts | 3 | 2025 | 160 | 0.560 |
Why?
|
| Intestinal Polyposis | 2 | 2015 | 16 | 0.560 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 69 | 0.560 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 151 | 0.530 |
Why?
|
| Testis | 2 | 2017 | 405 | 0.510 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 16 | 0.490 |
Why?
|
| Genes, Lethal | 2 | 2022 | 75 | 0.490 |
Why?
|
| Interleukins | 1 | 2015 | 119 | 0.430 |
Why?
|
| Ovary | 1 | 2017 | 358 | 0.430 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 808 | 0.420 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 443 | 0.390 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 257 | 0.370 |
Why?
|
| Mice, Transgenic | 9 | 2024 | 2311 | 0.360 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 71 | 0.350 |
Why?
|
| Genome | 4 | 2023 | 465 | 0.350 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 4445 | 0.340 |
Why?
|
| Mutation | 12 | 2024 | 5949 | 0.330 |
Why?
|
| Alleles | 7 | 2024 | 1610 | 0.330 |
Why?
|
| Transgenes | 3 | 2025 | 330 | 0.330 |
Why?
|
| Osteoporosis | 2 | 2021 | 134 | 0.320 |
Why?
|
| Integrases | 3 | 2023 | 153 | 0.300 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 623 | 0.290 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 51 | 0.290 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1045 | 0.290 |
Why?
|
| Phenotype | 10 | 2025 | 4309 | 0.290 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 11 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1932 | 0.290 |
Why?
|
| Stem Cells | 4 | 2024 | 682 | 0.280 |
Why?
|
| Mice, 129 Strain | 3 | 2018 | 97 | 0.280 |
Why?
|
| Gene Deletion | 5 | 2021 | 769 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 584 | 0.280 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 364 | 0.260 |
Why?
|
| Genes, Essential | 2 | 2024 | 43 | 0.260 |
Why?
|
| Chromosomes, Artificial | 1 | 2006 | 1 | 0.250 |
Why?
|
| Dependovirus | 2 | 2025 | 144 | 0.250 |
Why?
|
| Male | 24 | 2025 | 62895 | 0.250 |
Why?
|
| Genetic Vectors | 3 | 2025 | 891 | 0.250 |
Why?
|
| Female | 22 | 2025 | 68770 | 0.230 |
Why?
|
| Oocytes | 2 | 2024 | 281 | 0.230 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 15 | 0.230 |
Why?
|
| Cell Proliferation | 4 | 2022 | 2400 | 0.220 |
Why?
|
| Osteoclasts | 2 | 2025 | 64 | 0.220 |
Why?
|
| RANK Ligand | 1 | 2025 | 51 | 0.220 |
Why?
|
| Viral Tropism | 1 | 2025 | 41 | 0.220 |
Why?
|
| Epithelial Cells | 2 | 2022 | 873 | 0.220 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2004 | 34 | 0.220 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.220 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2004 | 90 | 0.210 |
Why?
|
| Zygote | 1 | 2024 | 28 | 0.210 |
Why?
|
| Macular Degeneration | 1 | 2025 | 89 | 0.210 |
Why?
|
| Eye Proteins | 1 | 2025 | 229 | 0.210 |
Why?
|
| Mice, Inbred Strains | 3 | 2023 | 291 | 0.210 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 87 | 0.200 |
Why?
|
| Gene Targeting | 1 | 2004 | 167 | 0.200 |
Why?
|
| DNA Helicases | 1 | 2025 | 229 | 0.200 |
Why?
|
| Capsid | 1 | 2023 | 90 | 0.200 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1569 | 0.200 |
Why?
|
| Flow Cytometry | 2 | 2018 | 755 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 524 | 0.200 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 113 | 0.200 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 325 | 0.200 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2023 | 66 | 0.190 |
Why?
|
| Ciliopathies | 1 | 2022 | 11 | 0.190 |
Why?
|
| Anophthalmos | 1 | 2023 | 24 | 0.190 |
Why?
|
| Exons | 3 | 2023 | 757 | 0.190 |
Why?
|
| Coloboma | 1 | 2023 | 41 | 0.190 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2021 | 84 | 0.190 |
Why?
|
| Microphthalmos | 1 | 2023 | 53 | 0.190 |
Why?
|
| Genotype | 5 | 2021 | 2600 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 141 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 302 | 0.190 |
Why?
|
| Eye Abnormalities | 1 | 2023 | 98 | 0.190 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 19 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 283 | 0.180 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2024 | 167 | 0.180 |
Why?
|
| Bone and Bones | 2 | 2021 | 300 | 0.180 |
Why?
|
| Retina | 1 | 2025 | 445 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1601 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2025 | 1100 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.180 |
Why?
|
| Pyroptosis | 1 | 2022 | 34 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 317 | 0.180 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.180 |
Why?
|
| Semaphorins | 1 | 2021 | 26 | 0.180 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.170 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 33 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2025 | 1206 | 0.170 |
Why?
|
| Synapses | 1 | 2024 | 433 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2023 | 2345 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 69 | 0.170 |
Why?
|
| Genomics | 2 | 2020 | 1548 | 0.160 |
Why?
|
| Introns | 1 | 2021 | 282 | 0.160 |
Why?
|
| Lung | 3 | 2024 | 1523 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 332 | 0.150 |
Why?
|
| Gene Expression | 3 | 2017 | 1487 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 12 | 0.150 |
Why?
|
| Gene Dosage | 3 | 2017 | 438 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.150 |
Why?
|
| Disease | 1 | 2020 | 123 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 66 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 63 | 0.140 |
Why?
|
| Neoplasm Proteins | 3 | 2013 | 656 | 0.140 |
Why?
|
| Bone Density | 1 | 2020 | 354 | 0.140 |
Why?
|
| Sex Determination Processes | 1 | 2018 | 11 | 0.140 |
Why?
|
| Pregnancy | 3 | 2024 | 7426 | 0.140 |
Why?
|
| Humans | 26 | 2025 | 127511 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2023 | 968 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 320 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 72 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 1207 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2314 | 0.130 |
Why?
|
| Sequence Deletion | 2 | 2017 | 511 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 271 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 858 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2019 | 438 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 109 | 0.130 |
Why?
|
| Complement C5a | 1 | 2016 | 19 | 0.130 |
Why?
|
| Transcriptome | 3 | 2022 | 1069 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 717 | 0.120 |
Why?
|
| Proteins | 3 | 2023 | 1019 | 0.120 |
Why?
|
| Wound Healing | 2 | 2022 | 450 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2021 | 4489 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 36 | 0.120 |
Why?
|
| Leydig Cells | 1 | 2016 | 21 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 498 | 0.120 |
Why?
|
| Sertoli Cells | 1 | 2016 | 76 | 0.120 |
Why?
|
| Meiosis | 1 | 2016 | 104 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2023 | 332 | 0.120 |
Why?
|
| Interleukin-33 | 1 | 2015 | 17 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 270 | 0.120 |
Why?
|
| Gene Knockout Techniques | 3 | 2022 | 131 | 0.120 |
Why?
|
| Mitosis | 1 | 2016 | 190 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2015 | 60 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 239 | 0.110 |
Why?
|
| Mast Cells | 1 | 2015 | 67 | 0.110 |
Why?
|
| Osteogenesis | 2 | 2024 | 162 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2015 | 186 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 228 | 0.110 |
Why?
|
| Base Sequence | 4 | 2022 | 2760 | 0.110 |
Why?
|
| Homozygote | 2 | 2022 | 540 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 533 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 418 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2015 | 82 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 234 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1283 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 2752 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 31 | 0.100 |
Why?
|
| Capsid Proteins | 2 | 2023 | 143 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2012 | 19 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2019 | 1509 | 0.090 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 26 | 0.090 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 129 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 79 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1008 | 0.090 |
Why?
|
| RNA, Messenger | 5 | 2013 | 2542 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 516 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 964 | 0.090 |
Why?
|
| Obesity | 2 | 2016 | 2338 | 0.080 |
Why?
|
| Cytokines | 1 | 2016 | 1326 | 0.080 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 9 | 0.080 |
Why?
|
| Genetic Therapy | 2 | 2025 | 683 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 539 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2025 | 979 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 1892 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1823 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 123 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2008 | 7 | 0.070 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 122 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 154 | 0.070 |
Why?
|
| Zebrafish | 2 | 2021 | 403 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 351 | 0.070 |
Why?
|
| Biometry | 1 | 2008 | 94 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 405 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 606 | 0.070 |
Why?
|
| Triglycerides | 1 | 2010 | 596 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2901 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 96 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 80 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 39 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 36 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2008 | 463 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 820 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 291 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 149 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 224 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3588 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2814 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2007 | 271 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 329 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 11 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 12 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2893 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2010 | 665 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 55 | 0.060 |
Why?
|
| Serogroup | 1 | 2025 | 65 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2025 | 363 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2004 | 45 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 283 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2021 | 14463 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 136 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2024 | 159 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 119 | 0.050 |
Why?
|
| X Chromosome | 1 | 2004 | 329 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2024 | 273 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 1206 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 63 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2004 | 336 | 0.050 |
Why?
|
| Colorimetry | 1 | 2022 | 17 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 24 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2022 | 42 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 183 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2022 | 74 | 0.050 |
Why?
|
| Cilia | 1 | 2022 | 76 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2022 | 30 | 0.050 |
Why?
|
| Smartphone | 1 | 2022 | 44 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2022 | 66 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 247 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 155 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2022 | 86 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2623 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 272 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 71 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 3051 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 222 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 90 | 0.040 |
Why?
|
| Bivalvia | 1 | 2001 | 7 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 113 | 0.040 |
Why?
|
| Binding Sites | 2 | 2017 | 1187 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 34 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2022 | 299 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 137 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2020 | 25 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2020 | 53 | 0.040 |
Why?
|
| Facies | 1 | 2021 | 156 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 167 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 109 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 202 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 91 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 159 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 373 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 204 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 198 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 573 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 99 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 265 | 0.040 |
Why?
|
| Methotrexate | 1 | 2022 | 317 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 511 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2022 | 450 | 0.040 |
Why?
|
| Cell Line | 1 | 2004 | 2565 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 770 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 662 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 320 | 0.040 |
Why?
|
| Genes | 1 | 2020 | 304 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2022 | 827 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 780 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 784 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 314 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 189 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 73 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 677 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 852 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1538 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 406 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1198 | 0.030 |
Why?
|
| Amino Acids | 1 | 2020 | 615 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 2080 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 727 | 0.030 |
Why?
|
| Complement Activation | 1 | 2016 | 49 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 233 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 347 | 0.030 |
Why?
|
| DNA Primers | 2 | 2007 | 604 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 203 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1485 | 0.030 |
Why?
|
| Neurons | 1 | 2024 | 1922 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3331 | 0.030 |
Why?
|
| Child | 3 | 2021 | 25298 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1730 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2999 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1664 | 0.020 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2012 | 11 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 847 | 0.020 |
Why?
|
| Lewis X Antigen | 1 | 2011 | 11 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 174 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 39 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 561 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 691 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 740 | 0.020 |
Why?
|
| RNA Splicing Factors | 1 | 2010 | 52 | 0.020 |
Why?
|
| Lipolysis | 1 | 2010 | 73 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 20156 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2010 | 86 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 222 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3720 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 88 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 327 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 236 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 296 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 689 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1315 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8371 | 0.020 |
Why?
|
| Neoplasms | 1 | 2022 | 2857 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2007 | 37 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1005 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 275 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 687 | 0.010 |
Why?
|
| Glucose | 1 | 2010 | 839 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9705 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 971 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 1765 | 0.010 |
Why?
|
| Hemocytes | 1 | 2001 | 4 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2001 | 27 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2001 | 37 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 622 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 687 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 477 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 30609 | 0.010 |
Why?
|
| Leukemia | 1 | 2001 | 356 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 650 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 2543 | 0.010 |
Why?
|